Brain Longevity Supplement for Cognitive Functioning
(CLARITY Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new brain supplement, the Novel Brain Longevity Supplement, which might improve memory and thinking skills. Researchers will assess its effectiveness by comparing it to a placebo (a look-alike pill with no active ingredients). Participants will take either the supplement or placebo for 8 weeks and report changes in cognitive function through online surveys. Adults in the U.S. who believe they could improve their mental sharpness by 30% or more may be suitable for this study. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research on cognitive enhancement.
Will I have to stop taking my current medications?
You may need to stop taking certain medications if they have a known interaction with the study product. This includes medications like anticoagulants, antidepressants, and others listed in the trial's exclusion criteria.
Is there any evidence suggesting that this treatment is likely to be safe for humans?
Research has shown that Urolithin A, a key component of the Novel Brain Longevity Supplement, is generally safe and well-tolerated. Studies with older adults have found no major side effects from Urolithin A, suggesting the supplement is likely safe. Its use in other health areas has also supported its safety profile. However, as with any new treatment, individual experiences may vary, so staying informed and consulting healthcare providers is important.12345
Why do researchers think this study treatment might be promising?
Researchers are excited about the Novel Brain Longevity Supplement because it uses Mitopure Urolithin A, a groundbreaking ingredient targeting cognitive health. Unlike current treatments for cognitive decline, which often focus on neurotransmitter support or neuroprotection, this supplement aims to enhance mitochondrial function, potentially boosting brain energy and improving cognitive performance. This unique mechanism offers a fresh approach to brain health, sparking interest in its potential benefits.
What evidence suggests that this supplement might be an effective treatment for cognitive function?
This trial will compare the Novel Brain Longevity Supplement, containing Urolithin A, with a placebo. Research suggests that Urolithin A might improve memory and learning. Animal studies have shown that Urolithin A can enhance brain functions like learning and memory, particularly in aging and brain disease models. One study found that long-term use of Urolithin A improved various brain functions in mice with Alzheimer's disease. Additionally, it might support the immune system as people age, offering protection against inflammation related to aging. While these findings are promising, they primarily come from animal studies, and more research is needed to confirm these effects in humans.13678
Who Is on the Research Team?
Susan Hewlings, PhD
Principal Investigator
Radicle Science Inc.
Are You a Good Fit for This Trial?
Adults in the USA concerned about cognitive functioning, brain fog, mental fatigue, or aging may qualify for this study. Participants will be randomly assigned to receive either a novel supplement with Urolithin A (Mitopure) or a placebo.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the study product (active or placebo) for 8 weeks and complete electronic surveys assessing cognitive function
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Novel Brain Longevity Supplement
Find a Clinic Near You
Who Is Running the Clinical Trial?
Amazentis SA
Lead Sponsor
Radicle Science (sponsor)
Collaborator